WORKING AT THE EDGE OF IMPOSIBLE TO HELP DELIVER BREAKTHROUGH CELL & GENE THERAPIES SUPPORTING A PIONEERING COMMUNITYWe provide pioneering companies with advanced technology and service solutions to accelerate the transition between laboratory research and clinical manufacture. WELCOME TO OXGENE OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. Our discovery technologies help pioneers advance their CAR-T, CRISPR, capsid or promoter discovery programmes. Our biomanufacturing solutions further accelerate the development and scalable manufacture of lentiviral, AAV or adenoviral vector based therapeutics. Our pioneering spirit fuels us; we're open minded, collaborative, responsive and ambitious. We push the boundaries of possibility to drive breakthrough therapeutics from laboratory research all the way to clinical manufacture. By combining WuXi ATU's world class cell and gene therapy CTDMO platform with OXGENE's innovative capabilities, we will be able to provide transformative solutions for our customers. DAVID CHANG, CEO, WUXI ADVANCED THERAPIES Dr Ryan Cawood Chief Scientific Officer, OXGENE and WuXi ATU OUR MISSION IS TO ACCELERATE SUCCESS TECHNOLOGY AT THE EDGE OF IMPOSSIBLE Based in Oxford, UK, we help cell and gene therapy pioneers accelerate development of their breakthrough therapeutics. Leadership Careers Then and Now: Interview with Ryan Cawood Our AwardsOur pioneering spirit drives our success. We're honoured to be recognised in the following awards. BE FIRST in the race to deliver breakthrough Cell & Gene Therapies CONTACT US Are you ready for GMP Manufacture? WuXi Advanced Therapies is a global Contract Testing, Development and Manufacturing Organization (CTDMO) dedicated to accelerating progress and time to market for cell and gene therapies. GMP MANUFACTURE